Understanding the genetic basis of kidney disease is important for identifying individuals at higher risk, implementing early interventions, and developing targeted therapies. Genetic testing and family history assessments can provide valuable information for assessing the genetic risk of kidney disease in certain individuals. Additionally, ongoing research in genomics and personalized medicine may lead to more effective strategies for the prevention and treatment of kidney diseases with a genetic component.
To describe the genetic landscape of cystic kidney diseases and the recent advances in the identification of genetic disorders of the kidney. The focus will be on monogenic kidney disease, but a consideration of genetic modifiers of kidney disease and risk alleles will be given. To describe how personalised medicine approaches have led to novel therapies for genetic cystic kidney diseases.
The scope includes summaries and reviews of different genetic disorders of the kidney including monogenic cystic disorders (autosomal dominant and recessive) as well as ciliopathy syndromes such as Bardet Biedl syndrome. The type of manuscripts will include case reports with literature reviews, reviews, commentary and basic research articles.
Keywords:
cystic kidney disease, ciliopathies, genomic, genetic, personalised medicine
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Understanding the genetic basis of kidney disease is important for identifying individuals at higher risk, implementing early interventions, and developing targeted therapies. Genetic testing and family history assessments can provide valuable information for assessing the genetic risk of kidney disease in certain individuals. Additionally, ongoing research in genomics and personalized medicine may lead to more effective strategies for the prevention and treatment of kidney diseases with a genetic component.
To describe the genetic landscape of cystic kidney diseases and the recent advances in the identification of genetic disorders of the kidney. The focus will be on monogenic kidney disease, but a consideration of genetic modifiers of kidney disease and risk alleles will be given. To describe how personalised medicine approaches have led to novel therapies for genetic cystic kidney diseases.
The scope includes summaries and reviews of different genetic disorders of the kidney including monogenic cystic disorders (autosomal dominant and recessive) as well as ciliopathy syndromes such as Bardet Biedl syndrome. The type of manuscripts will include case reports with literature reviews, reviews, commentary and basic research articles.
Keywords:
cystic kidney disease, ciliopathies, genomic, genetic, personalised medicine
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.